Stock & Company Details
C4 Therapeutics Inc $CCCC
Price:
46,691,331
111M
$412M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-3.55
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
CCCC technical indicators
Latest C4 Therapeutics Inc (CCCC) indicator readings as of 2026-08-10.
CCCC's 14-day RSI is 46.6, in neutral territory. At $3.62 it is trading 25.0% above its 200-day moving average of $2.90, and below its 50-day average of $3.92. Price sits in the middle of its Bollinger Bands ($3.41 to $3.85). ADX reads 15.5, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecule medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
Finance Bot
Ask your questions
Start by typing a question below.
